Treatment patterns, effectiveness, and safety of Trastuzumab in Chinese patients with metastatic gastric cancer: Interim analysis of the EVIDENCE registry study.

Shukui Qin,Shen Lin,Rui Hua Xu,Wuyun Su,Yong Tang,Xin Wang,Jianming Xu,Weiping Zhou,Tongjian Cui,Suxia Luo,Xiaohui Wu,Jiafu Ji

Treatment patterns, effectiveness, and safety of Trastuzumab in Chinese patients with metastatic gastric cancer: Interim analysis of the EVIDENCE registry study.

2017

Shukui Qin
Shen Lin
Rui Hua Xu
Wuyun Su
Yong Tang
Xin Wang
Jianming Xu
Weiping Zhou
Tongjian Cui
Suxia Luo
Xiaohui Wu
Jiafu Ji

e15595Background: Trastuzumab (TRA) was approved for HER2-positive metastatic gastric or gastroesophageal junction adenocarcinoma (mGC) in China in August 2012. However, real-world data on the trea...

Keywords:

Interim analysis
Oncology
Trastuzumab
Pathology
Metastatic gastric cancer
Medicine
Internal medicine
Gastroesophageal Junction Adenocarcinoma
registry study

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations